date:May 23, 2012
nificant reduction in the risk of all-cause and cardiovascular mortality in subjects with the metabolic syndrome.
We hope these findings will spur interventional randomized, controlled trials to confirm the effects of vitamin D on mortality and, if positive, help establish recommendations for supplementation in these subjects, wrote the authors, led by Neil Thomas from the University of Birmingham, England.
MetS
Metabolic syndrome (MetS) is a condition characterized by central obesity, hyp